1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Novavax, Inc.

Novavax, Inc.

NVAX
Novavax, Inc.US flagNASDAQ Global Select
10.21
USD
-0.30
- -
1.68BMarket Cap

Total Valuation

Novavax, Inc. carries a market capitalization of 1.68B, placing it among publicly traded companies globally. Its enterprise value stands at 827.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.68B
Enterprise Value827.83M

Share Statistics

Novavax, Inc. currently has 164.42M shares outstanding.

Shares Outstanding164.42M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Novavax, Inc. trades at a trailing price-to-earnings ratio of 8.96. The price-to-sales ratio is 2.22, and the price-to-book ratio stands at -0.29.

PE Ratio8.96
PS Ratio2.22
PB Ratio-0.29
P/TBV Ratio-5.14
P/FCF Ratio-14.85
P/OCF Ratio-14.45

Enterprise Valuation

The EV/Sales ratio of 1.39 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.03 provides insight into valuation relative to core operating earnings.

EV / Sales1.39
EV / EBITDA19.70
EV / EBIT42.03
EV / FCFN/A

Financial Position

Novavax, Inc. maintains a current ratio of 2.48, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -203.82, indicating conservative leverage, while an interest coverage ratio of 1.93 demonstrates limited ability to service its debt obligations.

Current Ratio2.48
Quick Ratio2.38
Debt / Equity-203.82
Debt / EBITDA7.02
Interest Coverage1.93

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-7.52
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-17.06
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover8.25

Taxes

Over the trailing twelve months, Novavax, Inc. has paid 1.65M in income taxes, reflecting an effective tax rate of 2.98.

Income Tax1.65M
Effective Tax Rate2.98

Stock Price Statistics

Novavax, Inc.'s stock has gained approximately 40.63361% over the past 52 weeks. The 50-day moving average sits at 8.87, while the 200-day moving average is 8.41.

Beta (5Y)N/A
52-Week Price Change40.63361%
50-Day Moving Average8.87
200-Day Moving Average8.41
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Novavax, Inc. generated 596.34M in revenue and converted that into -87.83M in net income, yielding earnings per share of -0.53. EBITDA reached 42.03M, while operating income came in at 19.70M.

Revenue596.34M
Gross Profit506.72M
Operating Income19.70M
Pretax Income-86.18M
Net Income-87.83M
EBITDA42.03M
EBIT19.70M
Earnings Per Share (EPS)-0.53

Balance Sheet

Novavax, Inc. holds 790.33M in cash and equivalents against 295.06M in total debt, resulting in a net debt position of 62.68M. Total book value stands at -4.58B, with working capital of 508.36M providing operational flexibility.

Cash & Cash Equivalents790.33M
Total Debt295.06M
Net Debt62.68M
Equity (Book Value)-4.58B
Book Value Per Share-28.15
Working Capital508.36M

Cash Flow

Novavax, Inc. produced -91.56M in operating cash flow over the past twelve months.

Operating Cash Flow-91.56M
Capital ExpendituresN/A
Free Cash Flow-91.56M
FCF Per Share-0.56

Margins

Novavax, Inc. operates with a gross margin of 84.97, reflecting its pricing power and cost economics. The operating margin of 3.30 and net profit margin of -14.73 provide insight into operational efficiency.

Gross Margin84.97
Operating Margin3.30
Pretax Margin-14.45
Profit Margin-14.73
EBITDA Margin7.05

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-5.48
FCF Yield-6.73

Stock Splits

Novavax, Inc.'s most recent stock split took place on May 10, 2019 with a 20:1 split ratio.

Last Split Date5/10/2019
Split Ratio20:1

Scores

Novavax, Inc. posts an Altman Z-Score of -4.85, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-4.85